Evaluating a Bidirectional Priming Intervention for Goals-of-care Communication in Oncology
Prime GOC
Development of a Bidirectional Priming Intervention for Goals-of-care Communication in Oncology
1 other identifier
interventional
40
1 country
1
Brief Summary
This pilot study will evaluate whether an intervention aimed at hospitalized patients with advanced lung and gastrointestinal cancers can help facilitate goals-of-care (GOC) communication with their oncologists after discharge. While GOC communication is a recommended component of routine oncology care, many patients with solid cancers do not have the opportunity to talk with their oncologist about their goals and end-of-life preferences. Prior research has shown that a systematic method of prompting GOC communication with at-risk patients would address a key barrier to timely GOC communication and ensure that patients receive care that is in line with their personal preferences. This trial will enroll 80 participants, who will be randomized 1:1 to either an intervention or a control group. Participants in the intervention group will complete a short survey regarding their goals, preferences, and disease understanding. Survey responses will be shared with each participant's outpatient oncology team. Oncologists will subsequently receive a nudge in the electronic medical record reminding them of key survey responses and encouraging them to discuss them at the patient's first clinic visit after hospital discharge. The primary feasibility outcome is intervention completion rate and the primary clinical outcome is GOC documentation within 30 days of discharge in the intervention group compared to the control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 25, 2025
CompletedFirst Posted
Study publicly available on registry
May 2, 2025
CompletedStudy Start
First participant enrolled
July 21, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 26, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedMarch 4, 2026
March 1, 2026
6 months
April 25, 2025
March 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Intervention Completion Rate
The primary feasibility outcome is intervention completion rate, defined as successful completion of the survey, response sharing, and electronic medical record nudge for all participants assigned to the intervention arm.
From enrollment to 30 days after hospital discharge
GOC Documentation
The presence of outpatient goals-of-care documentation in the electronic medical record within 30 days of hospital discharge as determined by manual review.
From enrollment to 30 days after hospital discharge
Study Arms (2)
Intervention
EXPERIMENTALParticipants in the intervention arm will complete a survey prior to hospital discharge. Their responses will be shared with each participant's outpatient oncology team.
Control
NO INTERVENTIONInterventions
13-item priming survey assessing patients' goals, treatment preferences, and disease understanding.
Eligibility Criteria
You may qualify if:
- Unplanned admission to the HUP Solid Oncology service;
- Underlying diagnosis of advanced lung or GI cancer, defined as metastatic or locally advanced disease;
- Anticipated discharge within the next 72h; and
- Primary oncologist is based at HUP; or
- Family member/caregiver of a patient meeting the above 4 criteria.
You may not qualify if:
- \. Unable to complete survey in English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Conquer Cancer Foundationcollaborator
- Abramson Cancer Center at Penn Medicinelead
Study Sites (1)
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 25, 2025
First Posted
May 2, 2025
Study Start
July 21, 2025
Primary Completion
January 26, 2026
Study Completion
March 1, 2026
Last Updated
March 4, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share